Texas Medical Center president Dr. Robert Robbins writes that the Supreme Court’s ruling that a gene is not an invention of man, but rather a naturally occurring event — and a company cannot hold a patent on nature — will open up abundant research opportunities for institutions within the Texas Medical Center and in other labs throughout the country to move forward with genetic sequencing and analysis aimed at finding new and better ways to treat diseases. However, the Justices ruled biotech companies can still patent the tests done on genes, and can still treat the databases of these tests as proprietary information. This concerns people like UTMB’s Dr. Howard Brody. He says these databases are not available to either the public or doctors because, the biotech companies argue, making the databases available could put the biotech companies at a disadvantage in the marketplace.